Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems
Alessandro Grillo, Giulia Chemi, Simone Brogi, et al.
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111674-111674
Open Access | Times Cited: 15

Showing 15 citing articles:

Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
Giuseppe Campiani, Caterina Cavella, J.D. Osko, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 14, pp. 9960-9988
Open Access | Times Cited: 44
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
Evaluation of novel compounds as anti-bacterial or anti-virulence agents
Brankica Filipić, Dušan Ušjak, Martina Hrast Rambaher, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
32nd Annual GP2A Medicinal Chemistry Conference
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
Nicola Relitti, A. Prasanth Saraswati, Giulia Chemi, et al.
European Journal of Medicinal Chemistry (2020) Vol. 212, pp. 112998-112998
Closed Access | Times Cited: 34
Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening
Hajar Sirous, Giuseppe Campiani, Vincenzo Calderone, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104808-104808
Open Access | Times Cited: 30
Chemical Profile, Antioxidant, Anti-Proliferative, Anticoagulant and Mutagenic Effects of a Hydroalcoholic Extract of Tuscan Rosmarinus officinalis
Stefania Lamponi, Maria Camilla Baratto, Elisabetta Miraldi, et al.
Plants (2021) Vol. 10, Iss. 1, pp. 97-97
Open Access | Times Cited: 29
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
Stefania Butini, Uwe Grether, Kwang‐Mook Jung, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1758-1782
Open Access | Times Cited: 4
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents
Alessandro Grillo, Filomena Fezza, Giulia Chemi, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 9, pp. 1716-1736
Open Access | Times Cited: 19
Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents
Alessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 12
Open Access | Times Cited: 7
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
Alessandro Papa, Silvia Pasquini, Francesca Galvani, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114952-114952
Closed Access | Times Cited: 11
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?
Domenico Fazio, Emanuele Criscuolo, Alessandra Piccoli, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 7, pp. 765-778
Closed Access | Times Cited: 16
An Approach to Pharmacological Targets of Pyrrole Family From Medicinal Chemistry Viewpoint
Mohsen Amini, Ebrahim Saeedian Moghadam, Katayoon Mireskandari, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 19, pp. 2486-2561
Closed Access | Times Cited: 9
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 469-469
Open Access | Times Cited: 4
Dopamine D3 receptor ligands: a patent review (2014–2020)
Rita Maria Concetta Di Martino, Andrea Cavalli, Giovanni Bottegoni
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 6, pp. 605-627
Closed Access | Times Cited: 1
Page 1

Scroll to top